AstraZeneca Share Price Up 12% but is Cancer Drug Enough?

AstraZeneca Share Price Up 12% but is Cancer Drug Enough?

The AstraZeneca share price has increased by more than 12% in November following a cancer drug breakthrough. Can international deals help AstraZeneca ...